Logo image of TNON

TENON MEDICAL INC (TNON) Stock Fundamental Analysis

NASDAQ:TNON - Nasdaq - US88066N3035 - Common Stock - Currency: USD

0.9035  +0.02 (+2.57%)

After market: 0.906 +0 (+0.28%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to TNON. TNON was compared to 187 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for TNON as it has an excellent financial health rating, but there are worries on the profitability. TNON is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

TNON had negative earnings in the past year.
TNON had a negative operating cash flow in the past year.
In the past 5 years TNON always reported negative net income.
TNON had a negative operating cash flow in each of the past 5 years.
TNON Yearly Net Income VS EBIT VS OCF VS FCFTNON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -102.38%, TNON is doing worse than 81.28% of the companies in the same industry.
With a Return On Equity value of -146.26%, TNON is not doing good in the industry: 68.98% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -102.38%
ROE -146.26%
ROIC N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
TNON Yearly ROA, ROE, ROICTNON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

TNON has a Gross Margin of 47.62%. This is comparable to the rest of the industry: TNON outperforms 41.71% of its industry peers.
TNON's Gross Margin has declined in the last couple of years.
TNON does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 47.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
TNON Yearly Profit, Operating, Gross MarginsTNON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

More info and screens

7

2. Health

2.1 Basic Checks

TNON does not have a ROIC to compare to the WACC, probably because it is not profitable.
TNON has more shares outstanding than it did 1 year ago.
TNON has more shares outstanding than it did 5 years ago.
TNON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
TNON Yearly Shares OutstandingTNON Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 1M 2M 3M
TNON Yearly Total Debt VS Total AssetsTNON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -8.88, we must say that TNON is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -8.88, TNON is doing worse than 78.61% of the companies in the same industry.
There is no outstanding debt for TNON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -8.88
ROIC/WACCN/A
WACC8.62%
TNON Yearly LT Debt VS Equity VS FCFTNON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

A Current Ratio of 5.46 indicates that TNON has no problem at all paying its short term obligations.
TNON has a Current ratio of 5.46. This is in the better half of the industry: TNON outperforms 79.14% of its industry peers.
TNON has a Quick Ratio of 5.19. This indicates that TNON is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.19, TNON belongs to the best of the industry, outperforming 80.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.46
Quick Ratio 5.19
TNON Yearly Current Assets VS Current LiabilitesTNON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

6

3. Growth

3.1 Past

TNON shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 71.34%, which is quite impressive.
TNON shows a small growth in Revenue. In the last year, the Revenue has grown by 2.27%.
The Revenue has been growing by 130.83% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)71.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.9%
Revenue 1Y (TTM)2.27%
Revenue growth 3Y173.6%
Revenue growth 5Y130.83%
Sales Q2Q%0.97%

3.2 Future

Based on estimates for the next years, TNON will show a quite strong growth in Earnings Per Share. The EPS will grow by 14.85% on average per year.
The Revenue is expected to grow by 57.36% on average over the next years. This is a very strong growth
EPS Next Y88.72%
EPS Next 2Y40.01%
EPS Next 3Y25.42%
EPS Next 5Y14.85%
Revenue Next Year26.87%
Revenue Next 2Y41.59%
Revenue Next 3Y46.6%
Revenue Next 5Y57.36%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
TNON Yearly Revenue VS EstimatesTNON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10M 20M 30M 40M
TNON Yearly EPS VS EstimatesTNON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for TNON. In the last year negative earnings were reported.
Also next year TNON is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
TNON Price Earnings VS Forward Price EarningsTNON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
TNON Per share dataTNON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

TNON's earnings are expected to grow with 25.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.01%
EPS Next 3Y25.42%

More info and screens

0

5. Dividend

5.1 Amount

TNON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

TENON MEDICAL INC

NASDAQ:TNON (6/20/2025, 8:00:49 PM)

After market: 0.906 +0 (+0.28%)

0.9035

+0.02 (+2.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-11 2025-08-11/amc
Inst Owners2.05%
Inst Owner Change12.84%
Ins Owners0.28%
Ins Owner Change0%
Market Cap6.86M
Analysts82.5
Price Target5.95 (558.55%)
Short Float %0.23%
Short Ratio0.05
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.38%
Min EPS beat(2)1.96%
Max EPS beat(2)10.79%
EPS beat(4)4
Avg EPS beat(4)9.14%
Min EPS beat(4)1.96%
Max EPS beat(4)15.97%
EPS beat(8)8
Avg EPS beat(8)20.07%
EPS beat(12)10
Avg EPS beat(12)-2.37%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-44.31%
Min Revenue beat(2)-47.97%
Max Revenue beat(2)-40.64%
Revenue beat(4)0
Avg Revenue beat(4)-29.61%
Min Revenue beat(4)-47.97%
Max Revenue beat(4)-2.88%
Revenue beat(8)0
Avg Revenue beat(8)-24.33%
Revenue beat(12)0
Avg Revenue beat(12)-19.48%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.78%
PT rev (3m)-41.67%
EPS NQ rev (1m)20.83%
EPS NQ rev (3m)70.31%
EPS NY rev (1m)0%
EPS NY rev (3m)65.84%
Revenue NQ rev (1m)-26.16%
Revenue NQ rev (3m)-39.67%
Revenue NY rev (1m)-23.39%
Revenue NY rev (3m)-36.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.09
P/FCF N/A
P/OCF N/A
P/B 0.73
P/tB 0.73
EV/EBITDA N/A
EPS(TTM)-15.34
EYN/A
EPS(NY)-0.97
Fwd EYN/A
FCF(TTM)-1.33
FCFYN/A
OCF(TTM)-1.32
OCFYN/A
SpS0.43
BVpS1.24
TBVpS1.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -102.38%
ROE -146.26%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 47.62%
FCFM N/A
ROA(3y)-185.03%
ROA(5y)-156.48%
ROE(3y)-844.8%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.76%
GM growth 5Y-8.18%
F-Score4
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.12%
Cap/Sales 2.04%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.46
Quick Ratio 5.19
Altman-Z -8.88
F-Score4
WACC8.62%
ROIC/WACCN/A
Cap/Depr(3y)391.88%
Cap/Depr(5y)N/A
Cap/Sales(3y)47.06%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)71.34%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.9%
EPS Next Y88.72%
EPS Next 2Y40.01%
EPS Next 3Y25.42%
EPS Next 5Y14.85%
Revenue 1Y (TTM)2.27%
Revenue growth 3Y173.6%
Revenue growth 5Y130.83%
Sales Q2Q%0.97%
Revenue Next Year26.87%
Revenue Next 2Y41.59%
Revenue Next 3Y46.6%
Revenue Next 5Y57.36%
EBIT growth 1Y2.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y27.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.78%
OCF growth 3YN/A
OCF growth 5YN/A